Clinical Research Directory
Browse clinical research sites, groups, and studies.
Individualizing Corticosteroid Use in Pneumonia
Sponsor: Mayo Clinic
Summary
In this study, researchers propose a unique (individualized) approach to steroid treatment seeking to give the right dose of steroid to the right patient and at the right time. This study seeks to compare usual care to an individualized steroid dosing strategy by testing a marker of inflammation in the blood called C- reactive protein (CRP). The overall goal is to reduce an individual's exposure to steroids and the risk of potential side effects thereby increasing the potential benefit of using steroids to control inflammation in pneumonia.
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
24
Start Date
2024-11-01
Completion Date
2027-12
Last Updated
2025-08-03
Healthy Volunteers
No
Conditions
Interventions
Dexamethasone
Administered intravenously or orally based on daily CRP values and CRP corticosteroid dosing algorithm
Locations (1)
Mayo Clinic Rochester
Rochester, Minnesota, United States